Skip to content

Pilot Deployment of ePNa Into Epic EHR

Development of SMART on FHIR (Fast Healthcare Interoperability Resources) Interoperable Clinical Decision Support (CDS) for Emergency Department (ED) Patients With Pneumonia & Pilot Deployment Into Novel Epic Electronic Health Record (EHR) Environments

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06008314
Acronym
ePNa-Epic
Enrollment
6917
Registered
2023-08-23
Start date
2025-02-01
Completion date
2026-06-30
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Keywords

Decision Support

Brief summary

Intermountain Health has developed a electronic decision support tool to help doctors provide the best care for pneumonia. The purpose of this study is to enhance the existing tool (called ePneumonia (electronic Pneumonia) or ePNa) so that it can be used at other institutions, and to test deployment of the tool at another institution's hospitals.

Detailed description

This study as funded by the AHRQ (Agency for Healthcare Research and Quality) involves making the current ePNa system a SMART on FHIR compatible application that will enable the same core software and processes to work across the Cerner and Epic electronic health record platforms. The investigators will then engage with emergency department providers and patients to improve user centered design, considering clinician preferences and feedback for use as well as patient needs for information. Finally, the investigators will evaluate the feasibility and acceptability via a pilot implementation trial of the interoperable ePNa platform at two Vanderbilt affiliated hospitals.

Interventions

OTHERePNa

Real-time, automated clinical decision support tool for pneumonia (called ePNa)

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
Vanderbilt University
CollaboratorOTHER
Stanford University
CollaboratorOTHER
Nathan Dean
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

For the baseline database and assessment of clinical outcomes, all data will be pulled from the Epic Clarity data warehouse. * 2500 patients that presented to the Vanderbilt and Wilson county EDs who are \>= 18 years old will be identified by ICD-10 codes for pneumonia or acute respiratory failure or sepsis with secondary pneumonia codes for the baseline database. * An additional 2500 patients that presented to the Vanderbilt and Wilson county EDs who are \>= 18 years old will be identified by having had conventional PA (posteroanterior) and lateral or portable CXRs (chest X-rays), independent of ICD-10 codes. * During the one year pilot trial, patients seen in the 2 EDs, who are \>= 18 years old will be identified by ICD(International Classification of Diseases)-10 codes for pneumonia or acute respiratory failure or sepsis with secondary pneumonia codes (estimated to comprise 1800 patients).

Exclusion criteria

For all above patients: 1. Patients seen with a history of recent trauma. 2. Subsequent episodes of pneumonia from the same patient within the study period. 3. Patients directly admitted to hospice/comfort care. 4. Patients admitted to a non-study hospital for further care. 5. Patients transferred from outside hospitals. For the groups selected by ICD-10 pneumonia codes, an additional exclusion is: • Patients without radiographic evidence of pneumonia or with clear radiographic evidence for an alternative diagnosis.

Design outcomes

Primary

MeasureTime frameDescription
14-day hospital-free days14 days after initial presentation to the emergency department14-day hospital-free days (a metric which captures outpatient disposition from the emergency department, secondary hospital admission, and length of stay)

Secondary

MeasureTime frame
30-day all-cause mortalityAt 30 days after initial ED presentation
ED length of stay (hours)At ED discharge
ICU length of stay (days)At ICU discharge
Number of patients admitted to floor who are subsequently transferred to ICU within 72 hoursAt 72 hours after inpatient admission
Time from ED presentation to first antibiotic dose (minutes)At time of first antibiotic dose

Contacts

Primary ContactValerie Aston, MBA
Valerie.Aston@imail.org801-507-4606
Backup ContactDavid Tomer, MS
David.Tomer@imail.org801-507-4694

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026